Moxifloxacin (Avelox) 400 mg film-coated tablets are indicated for the treatment of the following bacterial infections caused by susceptible strains: Respiratory tract infections: Acute exacerbations of chronic bronchitis, Community acquired pneumonia (CAP) including CAP caused by multi-drug resistant strains*, Acute sinusitis.
Uncomplicated skin and skin structure infections.
Uncomplicated pelvic inflammatory disease (i.e. infections of female upper genital tract, including salpingitis and endometritis).
Complicated skin and skin structure infections (incl. diabetic foot infections).
Complicated intraabdominal infections including polymicrobial infections such as abscesses.